CAS 1215358-58-9

Bilastine-d6

Produit contrôlé

CAS : 1215358-58-9

Applications Labelled Bilastine. It is a novel, nonsedating H1-antihistamine developed for symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.
References Van Cauwenberge, P., et al.: Clin. Exp. Allergy, 30, 891 (2000), Bauchau, V., et al.: Eur. Respir. J., 24, 758 (2004), Lehman, J., et al.: Drugs, 66, 2309 (2006),

Formule : C₂₈H₃₁D₆N₃O₃

Couleur et forme : White To Light Brown

Masse moléculaire : 469.65

Ref: TR-B385002

Bilastine-d6

CAS : 1215358-58-9

Bilastine-d6 is an analog of Bilastine, which is a potent inhibitor of kinases. It has been shown to have anticancer properties and induces apoptosis in tumor cells. Bilastine-d6 inhibits the activity of kinases that are involved in cell division and proliferation, making it a potential candidate for cancer treatment. Studies have also shown that Bilastine-d6 enhances the antitumor effects of artesunate and chloroquine in human cancer cells. This inhibitor can be detected in urine samples, making it suitable for use as a biomarker in cancer diagnosis and monitoring. Its potential as an anticancer agent makes Bilastine-d6 a promising avenue for further research into new cancer treatments.

Formule : C₂₈H₃₁D₆N₃O₃

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 469.65 g/mol

Ref: 3D-QYB35858